SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 10th, 2024 • Skye Bioscience, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMay 10th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 29, 2024, by and among Skye Bioscience, Inc., a Nevada corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 13th, 2024 • Skye Bioscience, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 13th, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of March 11, 2024, by and among Skye Bioscience, Inc., a Nevada corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).
SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 29, 2024, by and among Skye Bioscience, Inc., a Nevada corporation (the “Company”), and the Investors identified on Exhibit A...Securities Purchase Agreement • January 29th, 2024 • Skye Bioscience, Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 29th, 2024 Company Industry Jurisdiction
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 7th, 2018 • Invitae Corp • Services-medical laboratories • New York
Contract Type FiledNovember 7th, 2018 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of November 6, 2018 by and among Invitae Corporation, a Delaware corporation (the “Company”), and the Investors identified on Exhibit A attached hereto (each an “Investor” and collectively the “Investors”).